In a pathology laboratory, immunohistochemistry (IHC) turnaround time is influenced by more than staining duration alone. When case volumes increase, the ability to process multiple slides efficiently can become a major factor in how quickly results move from specimen preparation to diagnostic review.
This is where the throughput of an IHC stainer system matters. A well-designed high-throughput IHC stainer can help laboratories manage larger workloads, reduce waiting between batches, and make better use of available staff time.
Why IHC Throughput Matters for TAT
Turnaround time (TAT) refers to the time required to move a case through the laboratory workflow until the relevant result is available for review. For IHC, staining is only one part of this timeline.
When an automated IHC stainer can process only a limited number of slides at once, additional cases may need to wait for the next available run. Even if the staining protocol itself is predictable, these waiting periods can accumulate during busy periods.
For example, a laboratory receiving a steady stream of biopsy cases may not have a problem when daily demand is low. However, when several cases require multiple IHC markers at the same time, batch limitations can create a queue.
A higher-throughput workflow helps reduce this bottleneck by allowing more slides to enter the staining process without requiring every case to wait for a completely new cycle.
Batch Capacity Is More Than a Slide Count
When evaluating a high-throughput IHC stainer, laboratories should look beyond the maximum number of slides that can physically fit into the instrument.
The more important question is how that capacity affects daily workflow.
An effective IHC stainer system should ideally support:
Multiple slides within the same workflow
Continuous or flexible loading
Different staining protocols running according to laboratory requirements
Consistent processing conditions
Minimal manual intervention between batches
Clear monitoring of running time and reagent status
Continuous loading can be particularly useful when specimens arrive throughout the day rather than as one large batch. Instead of waiting for an entire run to finish, laboratory staff can manage incoming slides around the ongoing workflow.
This can make the difference between theoretical capacity and practical throughput.
How Throughput Influences Daily Workflow
Consider a laboratory handling several IHC cases during the same working day. If slides are processed in rigid batches, a case arriving shortly after a run begins may have to wait until that run is completed.
That waiting time does not necessarily improve staining quality. It simply increases the time before the slide reaches the pathologist.
An automated IHC stainer with flexible loading and multiple independent processing positions can help distribute work more efficiently. Staff can introduce new slides as workflow capacity becomes available rather than treating every case as part of one fixed batch.
This is especially relevant for laboratories handling variable workloads, where the number of slides can change significantly from one day to another.
TAT Depends on Both Processing Time and Workflow Queues
A shorter staining cycle can improve TAT, but cycle time alone does not determine laboratory efficiency.
A useful way to think about IHC TAT is:
TAT = processing time + waiting time + handling time
Reducing processing time is only one opportunity for improvement. If slides spend significant time waiting for the next available run, the laboratory may see limited gains even after adopting a faster protocol.
This is why throughput and workflow flexibility should be considered together.
For laboratories planning an IHC stainer system, the goal should not simply be to select the instrument with the highest nominal capacity. Instead, the system should match the laboratory's actual case flow, staffing pattern, marker workload, and expected growth.
Celnovte Biotech Solutions for More Efficient IHC Workflows
Celnovte Biotech's fully automated IHC solution combines automated staining instruments with IHC reagents and supporting workflow technologies. Its solution portfolio is designed around the broader pathology workflow rather than treating the stainer as an isolated piece of equipment.
For laboratories looking to improve throughput without making capacity the only selection criterion, the Celnovte Biotech CNT320 Fully Automated IHC/ISH Stainer provides one example of a flexible workflow approach. It supports up to 60 slides across six trays, continuous loading and unloading, customizable protocols, and LIS integration. Its stated turnaround time is ≤3.5 hours, with support for up to 180 tests per day depending on protocols and workflow conditions.
For laboratories with more demanding workflows, the Celnovte Biotech CNT360 Full Automatic IHC&ISH Stainer is designed for high-throughput applications. Its M1 and M2 configurations support 60 and 120 slides respectively, while the system is designed for multiple protocols and flexible loading during operation. Celnovte Biotech specifies a 2.5-hour turnaround time for the system.
The practical advantage is not simply having more slide positions. Continuous workflow management can help laboratories reduce idle periods between batches and keep cases moving as new specimens enter the laboratory.
When Should a Lab Prioritize IHC Throughput?
A higher-throughput workflow can be particularly valuable when:
Daily IHC volume is increasing
Multiple markers are frequently requested per case
Slides regularly wait for the next staining run
Staff spend significant time loading and unloading batches
TAT targets are becoming harder to maintain
The laboratory expects case volume to grow
Different IHC or related staining protocols need to be managed within the same workflow
In these situations, improving throughput may provide greater operational value than simply shortening an individual staining step.
Choose Throughput Based on Workflow, Not Capacity Alone
A high-throughput IHC stainer should ultimately be evaluated by how well it fits the laboratory's real workflow.
Slide capacity, TAT, continuous loading, protocol flexibility, automation level, and staff intervention all contribute to practical throughput. The right combination can help reduce waiting time while maintaining a consistent staining workflow.
For laboratories exploring an integrated approach, Celnovte Biotech's IHC solutions provide a broader view of automated pathology workflows, while its IHC product portfolio can help laboratories identify an appropriate automated IHC stainer system for their workflow.
Need help planning an automated IHC workflow? Contact Celnovte Biotech's service team to discuss instrument selection, workflow requirements, and technical support. Celnovte Biotech also provides hardware and software support, preventive maintenance, and priority response services to help laboratories maintain instrument availability.
